TKI's in CML: Passing the Baton

4em; ">
Dr. Gotlib serves on the Steering Committee of a Novartis-sponsored trial of midostaurin (PKC412) for systemic mastocytosis and is a member of the National Comprehensive Cancer Network’s Guidelines Committee for CML.

http://www.hematology.org/Publications/Hematologist/2010/5668.aspx